Get ahead of standard treatments for NRG1 fusion-positive cancer. Participating in a clinical trial for NRG1 fusion-positive cancer gives you access to the latest therapies.Call +1 844 627 7246
If your doctor has told you that your cancer is positive for the NRG1 fusion, it means that an important gene has fused with another, which can fuel the growth of many forms of cancer. The NRG1 gene is responsible for producing a protein called neuregulin 1, which is needed for normal development of the cardiovascular system and nervous system. However, in rare cases a gene can join together with another. These “fusion genes” may produce proteins that promote cancer.
Several drugs that target NRG1 fusions are in advanced stages of development, while others are recruiting patients for clinical trials. These drugs are designed to treat many different types of tumors that have spread, or metastasized, throughout the body. So, for example, if you have metastatic gastric cancer, you have been considering entering a pancreatic cancer clinical trial, or you have any other form of solid tumor that has spread, you could be a candidate for treatment with a novel therapy that attacks NRG1 fusion driven tumors.
A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments. That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.Access the matching tool
Massive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to clinical trials of new therapies. If you aren’t sure if your cancer is NRG1 fusion positive, that’s okay. Additional testing can help determine your exact diagnosis.
“Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“
I reached out to Massive Bio after learning of a recent breast cancer diagnosis of a family member. From free expert clinical trial matching to patient advocate support, Massive Bio was able to provide me with the necessary resources and knowledge to provide my family member the support they needed during their cancer journey.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
When my sister in-law was diagnosed with breast cancer, she did not have a good understanding of her options. I reached out to Massive Bio for help. Her assigned case resource and patient advocates quickly got in touch with her getting her diagnosis from her doctors, and providing options including clinical trials. The service Massive Bio provided was excellent, and made me realize how important to have a company like Massive Bio on your side when someone you know is fighting cancer.
We reached out to Massive Bio for a second opinion regarding my Mothers breast cancer diagnosis. Massive Bio provided us with alternative treatment options which were clinically proven to be more effective and with less side effects than the standard level of care our oncologist suggested. Their team was quick to respond, extremely knowledgeable, answered all of our questions. They continue to follow her case, gladly reviewing any new scans and results. We are so grateful for the time and effort they continue to put into her case. Thank you Massive Bio for giving us hope again!
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.
Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.Call +1 844 627 7246
Clinical trials test the latest scientific advancements in cancer treatment for NRG1 gene fusions and other alterations. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Cancer patients with gene alterations might gain access to promising drugs and innovative treatments long before they're made available to the public.
At Massive Bio, our goal is to ensure that all cancer patients have access to clinical trials of innovative new treatments that offer hope for improved outcomes. Our unique SYNERGY-AI technology rapidly generates a personalized clinical trial matching report, which is FREE to patients and doctors.